Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis

EU orphan designation number: EU/3/09/689   
Active ingredient: Peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis
Indication: Treatment of myasthenia gravis
Sponsor: CuraVac Europe SA
Avenue de Villefranche 80, 1330 Rixensart, Belgique

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2009 Orphan designation EMEA/OD/078/09 (2009)8764 of 09/11/2009
24/01/2014 Change of name and/or address of sponsor